Potential Masking of Airway Eosinophilic Inflammation by Combination Therapy in Asthma

PURPOSE: Long-acting β(2) agonists (LABA) may mask ongoing bronchial inflammation, leaving asthmatic patients at greater risk of severe complications. The aim of this study was to compare the effect of combination therapy using low-dose inhaled corticosteroids (ICS) plus LABA on airway inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Byung-Jae, Jeung, Yun-Jin, Lee, Jin-Young, Oh, Mi-Jung, Choi, Dong-Chull
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2014
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936048/
https://www.ncbi.nlm.nih.gov/pubmed/24587956
http://dx.doi.org/10.4168/aair.2014.6.2.175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936048/
https://www.ncbi.nlm.nih.gov/pubmed/24587956
http://dx.doi.org/10.4168/aair.2014.6.2.175

Ejemplares similares